244 related articles for article (PubMed ID: 35136060)
1. Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate.
Liu S; Paknejad N; Zhu L; Kihara Y; Ray M; Chun J; Liu W; Hite RK; Huang XY
Nat Commun; 2022 Feb; 13(1):731. PubMed ID: 35136060
[TBL] [Abstract][Full Text] [Related]
2. Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer.
Peyruchaud O
Anticancer Agents Med Chem; 2009 May; 9(4):381-91. PubMed ID: 19442039
[TBL] [Abstract][Full Text] [Related]
3. Different signaling pathway between sphingosine-1-phosphate and lysophosphatidic acid in Xenopus oocytes: functional coupling of the sphingosine-1-phosphate receptor to PLC-xbeta in Xenopus oocytes.
Noh SJ; Kim MJ; Shim S; Han JK
J Cell Physiol; 1998 Aug; 176(2):412-23. PubMed ID: 9648929
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
5. Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells.
Itoh R; Miura S; Takimoto A; Kondo S; Sano H; Hiraki Y
J Bone Miner Metab; 2010 Nov; 28(6):659-71. PubMed ID: 20458606
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects.
Chun J; Giovannoni G; Hunter SF
Drugs; 2021 Feb; 81(2):207-231. PubMed ID: 33289881
[TBL] [Abstract][Full Text] [Related]
7. A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay.
Fleming JK; Glass TR; Lackie SJ; Wojciak JM
J Lipid Res; 2016 Sep; 57(9):1737-47. PubMed ID: 27444045
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil sphingosine 1-phosphate and lysophosphatidic acid receptors in pneumonia.
Rahaman M; Costello RW; Belmonte KE; Gendy SS; Walsh MT
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):233-41. PubMed ID: 16224106
[TBL] [Abstract][Full Text] [Related]
9. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.
Wang DA; Lorincz Z; Bautista DL; Liliom K; Tigyi G; Parrill AL
J Biol Chem; 2001 Dec; 276(52):49213-20. PubMed ID: 11604399
[TBL] [Abstract][Full Text] [Related]
10. Cell surface receptors in lysophospholipid signaling.
Anliker B; Chun J
Semin Cell Dev Biol; 2004 Oct; 15(5):457-65. PubMed ID: 15271291
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
Goetzl EJ; Kong Y; Mei B
J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
Gibbs TC; Rubio MV; Zhang Z; Xie Y; Kipp KR; Meier KE
Prostate; 2009 Oct; 69(14):1493-506. PubMed ID: 19536794
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.
Im DS
Acta Pharmacol Sin; 2010 Sep; 31(9):1213-22. PubMed ID: 20729877
[TBL] [Abstract][Full Text] [Related]
14. A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor.
Holdsworth G; Osborne DA; Pham TT; Fells JI; Hutchinson G; Milligan G; Parrill AL
BMC Biochem; 2004 Aug; 5():12. PubMed ID: 15298705
[TBL] [Abstract][Full Text] [Related]
15. A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors.
Cheng L; Su L; Tian X; Xia F; Zhao C; Yan W; Shao Z
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35758708
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.
Shida D; Fang X; Kordula T; Takabe K; Lépine S; Alvarez SE; Milstien S; Spiegel S
Cancer Res; 2008 Aug; 68(16):6569-77. PubMed ID: 18701480
[TBL] [Abstract][Full Text] [Related]
17. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
Lee CW; Rivera R; Dubin AE; Chun J
J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
[TBL] [Abstract][Full Text] [Related]
18. Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition.
Yuan Y; Jia G; Wu C; Wang W; Cheng L; Li Q; Li Z; Luo K; Yang S; Yan W; Su Z; Shao Z
Cell Res; 2021 Dec; 31(12):1263-1274. PubMed ID: 34526663
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into sphingosine-1-phosphate receptor activation.
Yu L; He L; Gan B; Ti R; Xiao Q; Hu H; Zhu L; Wang S; Ren R
Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117716119. PubMed ID: 35412894
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes.
Rao TS; Lariosa-Willingham KD; Lin FF; Palfreyman EL; Yu N; Chun J; Webb M
Brain Res; 2003 Nov; 990(1-2):182-94. PubMed ID: 14568343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
